{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:06:26Z","timestamp":1785434786612,"version":"3.56.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,17]]},"DOI":"10.7759\/cureus.90307","type":"journal-article","created":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T16:09:49Z","timestamp":1755446989000},"source":"Crossref","is-referenced-by-count":2,"title":["Comparative Effectiveness of Pitavastatin Versus Atorvastatin on Lipid Profile and Blood Sugar in Patients of Diabetic Dyslipidemia: An Open-Label Comparative Study"],"prefix":"10.7759","author":[{"given":"Gayatri","family":"Devi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baljinder Pal S","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/cmi.cmi_92_24","article-title":"Diabetes risk evaluation using Indian diabetes risk score among adults of an urban slum in Bengaluru, Karnataka","volume":"23","author":"Saraswathi S","year":"2025","unstructured":"Saraswathi S, Mukhopadhyay A, Sumana M, Debata I, Panda PS. Diabetes risk evaluation using Indian diabetes risk score among adults of an urban slum in Bengaluru, Karnataka. Curr Med Issues. 2025, 23:12-7. 10.4103\/cmi.cmi_92_24","journal-title":"Curr Med Issues"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.13.04135","article-title":"Prevalence and risk factors associated with undiagnosed diabetes in India: insights from NFHS-5 national survey","volume":"13","author":"Sahadevan P","year":"2023","unstructured":"Sahadevan P, Kamal VK, Sasidharan A, Bagepally BS, Kumari D, Pal A. Prevalence and risk factors associated with undiagnosed diabetes in India: insights from NFHS-5 national survey. J Glob Health. 2023, 13:04135. 10.7189\/jogh.13.04135","journal-title":"J Glob Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-S345","article-title":"American Diabetes Association indications for statins in diabetes: is there evidence?","volume":"32","author":"Eldor R","year":"2009","unstructured":"Eldor R, Raz I. American Diabetes Association indications for statins in diabetes: is there evidence?. Diabetes Care. 2009, 32:S384-91. 10.2337\/dc09-S345","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab M","year":"2011","unstructured":"Navab M, Reddy ST, Van Lenten BJ, Fogelman AM. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol. 2011, 8:222-32. 10.1038\/nrcardio.2010.222","journal-title":"Nat Rev Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31950-6","article-title":"Pharmacological lipid-modification therapies for prevention of ischaemic heart disease: current and future options","volume":"394","author":"Ray KK","year":"2019","unstructured":"Ray KK, Corral P, Morales E, Nicholls SJ. Pharmacological lipid-modification therapies for prevention of ischaemic heart disease: current and future options. Lancet. 2019, 394:697-708. 10.1016\/S0140-6736(19)31950-6","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008226.pub3","article-title":"Atorvastatin for lowering lipids","volume":"3","author":"Adams SP","year":"2015","unstructured":"Adams SP, Tsang M, Wright JM. Atorvastatin for lowering lipids. Cochrane Database Syst Rev. 2015, 3:CD008226. 10.1002\/14651858.CD008226.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0269-5","article-title":"Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control","volume":"49","author":"Nakata M","year":"2006","unstructured":"Nakata M, Nagasaka S, Kusaka I, Matsuoka H, Ishibashi S, Yada T. Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control. Diabetologia. 2006, 49:1881-92. 10.1007\/s00125-006-0269-5","journal-title":"Diabetologia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2017\/23741.9427","article-title":"Effect of atorvastatin on glycaemic parameters in normoglycaemic and prediabetic subjects: a prospective, panel study","volume":"11","author":"Parida S","year":"2017","unstructured":"Parida S, Swain TR, Routray SN, Maiti R. Effect of atorvastatin on glycaemic parameters in normoglycaemic and prediabetic subjects: a prospective, panel study. J Clin Diagn Res. 2017, 11:FC04-9. 10.7860\/JCDR\/2017\/23741.9427","journal-title":"J Clin Diagn Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S13492","article-title":"Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus","volume":"5","author":"Kawai Y","year":"2011","unstructured":"Kawai Y, Sato-Ishida R, Motoyama A, Kajinami K. Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus. Drug Des Devel Ther. 2011, 5:283-97. 10.2147\/DDDT.S13492","journal-title":"Drug Des Devel Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5688(11)70886-8","article-title":"Pitavastatin: an overview","volume":"12","author":"Saito Y","year":"2011","unstructured":"Saito Y. Pitavastatin: an overview. Atheroscler Suppl. 2011, 12:271-6. 10.1016\/S1567-5688(11)70886-8","journal-title":"Atheroscler Suppl"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5688(11)70888-1","article-title":"Pitavastatin: clinical effects from the LIVES study","volume":"12","author":"Teramoto T","year":"2011","unstructured":"Teramoto T. Pitavastatin: clinical effects from the LIVES study. Atheroscler Suppl. 2011, 12:285-8. 10.1016\/S1567-5688(11)70888-1","journal-title":"Atheroscler Suppl"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5455\/2319-2003.ijbcp20150237","article-title":"A comparative study of efficacy and safety of pitavastatin versus atorvastatin in the patients of dyslipidemia in medicine department of a tertiary care teaching hospital","volume":"4","author":"Vasani P","year":"2015","unstructured":"Vasani P, Savsani D, Mehta D, Bhatt P, Solanki S. A comparative study of efficacy and safety of pitavastatin versus atorvastatin in the patients of dyslipidemia in medicine department of a tertiary care teaching hospital. Int J Basic Clin Pharmacol. 2015, 4:24-9. 10.5455\/2319-2003.ijbcp20150237","journal-title":"Int J Basic Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2008.05.017","article-title":"A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance","volume":"30","author":"Sasaki J","year":"2008","unstructured":"Sasaki J, Ikeda Y, Kuribayashi T, et al.. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Clin Ther. 2008, 30:1089-101. 10.1016\/j.clinthera.2008.05.017","journal-title":"Clin Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2008.02.008","article-title":"Multicenter collaborative randomized parallel group comparative study of pitavastatin and atorvastatin in Japanese hypercholesterolemic patients: collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis prevention (CHIBA study)","volume":"201","author":"Yokote K","year":"2008","unstructured":"Yokote K, Bujo H, Hanaoka H, et al.. Multicenter collaborative randomized parallel group comparative study of pitavastatin and atorvastatin in Japanese hypercholesterolemic patients: collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis prevention (CHIBA study). Atherosclerosis. 2008, 201:345-52. 10.1016\/j.atherosclerosis.2008.02.008","journal-title":"Atherosclerosis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5551\/jat.e1008","article-title":"Influence of statins on glucose tolerance in patients with type 2 diabetes mellitus: subanalysis of the collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis prevention (CHIBA study)","volume":"16","author":"Yokote K","year":"2009","unstructured":"Yokote K, Saito Y. Influence of statins on glucose tolerance in patients with type 2 diabetes mellitus: subanalysis of the collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis prevention (CHIBA study). J Atheroscler Thromb. 2009, 16:297-8. 10.5551\/jat.e1008","journal-title":"J Atheroscler Thromb"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2013.03.008","article-title":"Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study","volume":"62","author":"Kurogi K","year":"2013","unstructured":"Kurogi K, Sugiyama S, Sakamoto K, et al.. Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study. J Cardiol. 2013, 62:87-94. 10.1016\/j.jjcc.2013.03.008","journal-title":"J Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2217\/clp.09.20","article-title":"Pitavastatin compared with atorvastatin in primary hypercholesterolemia or combined dyslipidemia","volume":"4","author":"Budinski D","year":"2009","unstructured":"Budinski D, Arneson V, Hounslow N, Gratsiansky N. Pitavastatin compared with atorvastatin in primary hypercholesterolemia or combined dyslipidemia. J Clin Lipidol. 2009, 4:291-302. 10.2217\/clp.09.20","journal-title":"J Clin Lipidol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/391725-comparative-effectiveness-of-pitavastatin-versus-atorvastatin-on-lipid-profile-and-blood-sugar-in-patients-of-diabetic-dyslipidemia-an-open-label-comparative-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T16:09:50Z","timestamp":1755446990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/391725-comparative-effectiveness-of-pitavastatin-versus-atorvastatin-on-lipid-profile-and-blood-sugar-in-patients-of-diabetic-dyslipidemia-an-open-label-comparative-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,17]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.90307","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,17]]}}}